Safety and toxicity of amphotericin B in glucose 5% or intralipid 20% in neutropenic patients with pneumonia or fever of unknown origin: randomised study. - Wikidata - awgldk - TriplyDB

Safety and toxicity of amphotericin B in glucose 5% or intralipid 20% in neutropenic patients with pneumonia or fever of unknown origin: randomised study.

Safety and toxicity of amphotericin B in glucose 5% or intralipid 20% in neutropenic patients with pneumonia or fever of unknown origin: randomised study.

http://www.wikidata.org/entity/Q33824631

about

Amphotericin B lipid soluble formulations versus amphotericin B in cancer patients with neutropenia Comparison of effects of amphotericin B deoxycholate infused over 4 or 24 hours: randomised controlled trial Efficacy and safety of amphotericin B lipid-based formulations-A systematic review and meta-analysis.Amphotericin B lipid soluble formulations vs amphotericin B in cancer patients with neutropenia.Fungal infection-related mortality versus total mortality as an outcome in trials of antifungal agents.Lipid-based amphotericin B for the treatment of fungal infections.Systematic review and meta-analysis of the tolerability and hepatotoxicity of antifungals in empirical and definitive therapy for invasive fungal infection.Comparison of the toxicity of amphotericin B in 5% dextrose with that of amphotericin B in fat emulsion in a randomized trial with cancer patients Amphotericin B and its new formulations: pharmacologic characteristics, clinical efficacy, and tolerability.Pulmonary reactions during treatment with amphotericin B: review of published cases and guidelines for management.Adverse effects of antifungal therapies in invasive fungal infections: review and meta-analysis.Diagnosis and therapy of Candida infections: joint recommendations of the German Speaking Mycological Society and the Paul-Ehrlich-Society for Chemotherapy.Role of diuretics and lipid formulations in the prevention of amphotericin B-induced nephrotoxicity.Amphotericin B in children with malignant disease: a comparison of the toxicities and pharmacokinetics of amphotericin B administered in dextrose versus lipid emulsion.Efficacy and safety of amphotericin B formulations: a network meta-analysis and a multicriteria decision analysis.Availability of lipid emulsion in obstetric anaesthesia in the UK: a national questionnaire survey.Reduction of amphotericin B-induced renal tubular apoptosis by N-acetylcysteine.Update on antifungal treatment of invasive Candida and Aspergillus infections.New agents for the treatment of systemic fungal infections--current status.Lipid emulsion to treat overdose of local anaesthetic.

P2860

Q24193811-FF71F579-156F-4FD2-99B8-74AAF177E787 Q28359772-50007BAE-6CA9-48C2-A756-E7FA270B0F73 Q30240770-0662C21E-28CF-4D44-8812-4F87807A7074 Q30887348-60F518A5-7FAB-4119-9816-6B5E4276DFE3 Q33253851-F3B9A2FC-20CE-4685-9740-C99D18BD5C5E Q33604227-8D439E67-C657-4342-B6EE-3D363A8B0820 Q33876645-8DBF0B84-0DC5-4127-8D86-0F0FAE2389E6 Q33976955-E9D430FE-65FE-4F47-8550-DB6C3EF240C9 Q34294886-CDD5F1A8-BB38-4C81-B3A4-6D25A681FF73 Q34350416-DBD32EDD-FBF5-466B-9A16-ACB222C57E54 Q36042366-B9376A71-42CC-4780-872B-6BC1F570A9FA Q37889382-6B3D9983-67D4-4EE4-B56F-E4BFAFC86FEE Q38077678-8AE12B89-AC67-479F-94D8-452867AD02BE Q39470922-4A0C01A0-49A4-4E34-93D5-5DB398BA33E3 Q40043040-4C2AAAB2-38B2-4FCC-B26F-651B9F3726EE Q40114318-BED4FA2D-65B7-4832-8E41-45E4BCBF1C5C Q43102684-CE795F7C-4AF2-4106-9D36-8C75227EB23C Q45017863-CCEC027F-E08B-40D1-8027-EABB8B936EF0 Q46576615-49C7B80A-B2AA-45BC-9FF9-EDE48F944710 Q48697599-E5F8645A-C2CA-40CA-9110-65B828FF4867

P2860

Safety and toxicity of amphotericin B in glucose 5% or intralipid 20% in neutropenic patients with pneumonia or fever of unknown origin: randomised study.

http://www.wikidata.org/entity/Q33824631

description

1998 nî lūn-bûn

@nan

1998 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

1998 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

1998年の論文

@ja

1998年論文

@yue

1998年論文

@zh-hant

1998年論文

@zh-hk

1998年論文

@zh-mo

1998年論文

@zh-tw

1998年论文

@wuu

name

Safety and toxicity of amphote ...... nown origin: randomised study.

@ast

Safety and toxicity of amphote ...... nown origin: randomised study.

@en

type

label

Safety and toxicity of amphote ...... nown origin: randomised study.

@ast

Safety and toxicity of amphote ...... nown origin: randomised study.

@en

prefLabel

Safety and toxicity of amphote ...... nown origin: randomised study.

@ast

Safety and toxicity of amphote ...... nown origin: randomised study.

@en

P1433

Q33824631-2A066C99-84BE-4734-925F-19393837996E

P1476

Q33824631-BC727FC6-0143-4D82-BBF5-9AC61B5AC306

P2093

Q33824631-00BE7E8F-4EFB-4BCC-879C-AFA2F8741CCA

Q33824631-11A7D83E-58A2-4D70-B2BA-F60EA3625BFD

Q33824631-33063841-6958-4EF1-B194-D676792CB3E5

Q33824631-6E4861F6-06EC-4B40-AC18-78375EE254C8

Q33824631-B655BED7-DAB8-462D-B48A-DFA381E929CC

Q33824631-C5B661A9-A038-4197-84DF-BA76D0E62B2F

Q33824631-D5524CB7-F8CF-4252-A651-79976BF5179A

Q33824631-EBA6E790-96BF-400A-BB42-FAA0E5660FB5

P2860

Q33824631-0C7D9B9E-DDDB-4EDE-B7E5-4CEF6B1411E9

Q33824631-2FCC09D9-07DE-40ED-858C-982AF93E7811

Q33824631-367B938F-B1E6-448F-A413-C9912E961262

Q33824631-3A74E3D4-C4A5-4CAF-8336-60EDD6C65D1C

Q33824631-41EC7B1F-F295-4A10-8F80-E9BC5EFC896A

Q33824631-604346E3-E8BE-4FAE-8FF1-4281ACC65C8D

Q33824631-6D5B6B99-0427-4DAC-802D-7F9959D23B8E

Q33824631-82E2C50F-DE11-47AD-8D1A-742BEFBEA999

Q33824631-9381CB4D-9259-4888-A305-FDE29EF4504D

Q33824631-B304EF77-FEB3-4D7D-83D8-12DEB4BE9C28

P304

Q33824631-68C65517-BD37-4F8E-85E0-2BA4828BE7DB

P31

Q33824631-679EECEB-BCA3-42C5-B665-BC2632E0EDD3

P356

Q33824631-2E333A21-020A-411A-8D34-2D86BE102D9D

P407

Q33824631-FF1A26BA-CC45-4B87-AB8C-793D9825801B

P433

Q33824631-9F61A795-C791-4B03-A84C-69A9CE4B7418

P478

Q33824631-3268BA01-96B1-4181-87B6-A9D4503B4F0B

P577

Q33824631-6C5C5AD3-7E39-4A8E-B2AD-DB8BD3A897D0

P5875

Q33824631-39C351EA-CA15-4795-A71B-7316BB501078

P698

Q33824631-0958B83A-19B1-4BFF-80EA-4AD3B4D5FE9B

P932

Q33824631-BB34FA1C-3048-493B-9E70-243CE9FD59B9

P356

BMJ.317.7155.379

P1433

P1476

Safety and toxicity of amphote ...... nown origin: randomised study.

@en

P2093

A Ganser

http://www.w3.org/2001/XMLSchema#string

C H Köhne

http://www.w3.org/2001/XMLSchema#string

D Petersen

http://www.w3.org/2001/XMLSchema#string

H Hecker

http://www.w3.org/2001/XMLSchema#string

M Freund

http://www.w3.org/2001/XMLSchema#string

P Schöffski

http://www.w3.org/2001/XMLSchema#string

R Wunder

http://www.w3.org/2001/XMLSchema#string

U Schubert

http://www.w3.org/2001/XMLSchema#string

P2860

In vitro renal toxicity and in vivo therapeutic efficacy in experimental murine cryptococcosis of amphotericin B (Fungizone) associated with Intralipid

Systemically administered antifungal agents. A review of their clinical pharmacology and therapeutic applications.

Administering amphotericin B--a practical approach.

Amphotericin B toxicity reduced by administration in fat emulsion.

Amphotericin B in a lipid emulsion for the treatment of cryptococcal meningitis in AIDS patients.

Trial of glucose versus fat emulsion in preparation of amphotericin for use in HIV infected patients with candidiasis.

Reduced renal toxicity and improved clinical tolerance of amphotericin B mixed with intralipid compared with conventional amphotericin B in neutropenic patients.

Clinical evaluation of a new lipid-based delivery system for intravenous administration of amphotericin B.

Clinical and pharmacokinetic evaluation of a new lipid-based delivery system of amphotericin B in AIDS patients.

Fungal infections in cancer patients: an international autopsy survey.

P304

379-384

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/BMJ.317.7155.379

http://www.w3.org/2001/XMLSchema#string

P407

P433

7155

http://www.w3.org/2001/XMLSchema#string

P478

317

http://www.w3.org/2001/XMLSchema#string

P577

1998-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

13590013

http://www.w3.org/2001/XMLSchema#string

P698

9694753

http://www.w3.org/2001/XMLSchema#string

P932

28631

http://www.w3.org/2001/XMLSchema#string